Mezzion Pharmaceuticals, Inc
- | Biotech or pharma, therapeutic R&D
Mezzion is a pharmaceutical company focused on rare diseases, currently in late-stage development of the first treatment designed for the 70,000 individuals living with single ventricle congenital heart disease. Annual peak sales are projected to reach $2.4 billion.
Address
Fort LeeNJ
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}